Prospective MD Anderson Dysphagia Inventory Outcomes After Nonsurgical Treatment of Locoregionally Advanced Oropharyngeal Carcinoma

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2015.12.327
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dysphagia in Oropharyngeal Squamous Cell Carcinoma in Perspective

Cancer
Cancer ResearchOncology
2017English

Neoadjuvant Treatment: The MD Anderson Experience

Breast Cancer Research
Cancer ResearchOncology
2005English

Approaching Oropharyngeal Dysphagia

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2004English

Hearing After Induction Chemotherapy and Definitive Chemoradiotherapy in Advanced Oropharyngeal Carcinoma

2018English

Cytomembranic PD-L1 Expression in Locoregionally Advanced Nasopharyngeal Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma: Incidence, Survival, Prognostic Factors, and Treatment Outcomes

Oncotarget
Oncology
2017English

Outcomes of Phase I Clinical Trials for Patients With Advanced Pancreatic Cancer: Update of the MD Anderson Cancer Center Experience

Oncotarget
Oncology
2017English

The Semisolid Bolus Swallow Test for Clinical Diagnosis of Oropharyngeal Dysphagia: A Prospective Randomised Study

European Archives of Oto-Rhino-Laryngology
MedicineOtorhinolaryngology
2011English

Is Pretreatment Epstein-Barr Virus DNA Still Associated With 6-Year Survival Outcomes in Locoregionally Advanced Nasopharyngeal Carcinoma?

Journal of Cancer
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy